Vistagen targets transformative SAD drug approval with top-line PALISADE-3 data in Q4 2025 while advancing differentiated neuroscience pipeline
  Coverage questions mute enthusiasm for HIV drug approval
  FDA Raises Manufacturing Concerns, Delays Unicycive's Kidney Disease Drug Approval
  FDA wants to use AI to speed up drug approval process
  How will FDA changes reshape drug approval in 2025 and beyond? - Chemical ' Engineering News
  Novavax Approval Process a Potential ‘Harbinger’ of Threat to FDA Integrity: Former Regulators
  FDA to Meet Drug Approval Goals Despite Cuts, Commissioner Says
  UroGen Pharma: ODAC Decision Puts Drug Approval In Limbo, But It's Not Over, Either - Seeking Alpha